67 filings
Page 3 of 4
8-K
1488g8 ou
11 May 21
Applied Therapeutics Reports First Quarter 2021 Financial Results
7:24am
8-K
1ppx4oein8qt
18 Mar 21
Applied Therapeutics Reports Fourth Quarter and Year-end 2020 Financial Results
7:22am
8-K
f2qn56n1mq7fk7ym0jc
17 Feb 21
Entry into a Material Definitive Agreement
5:05pm
8-K
jz8z04ez0
12 Nov 20
Applied Therapeutics Reports Third Quarter 2020 Financial Results
7:07am
8-K
urp96858kdsgmis
17 Aug 20
Other Events
8:25am
8-K
hqagt3r
11 Aug 20
Applied Therapeutics Reports Second Quarter 2020 Financial Results
7:07am
8-K
12cycjtx
5 Jun 20
Departure of Directors or Certain Officers
4:48pm
8-K
m6r7sa6
26 May 20
Departure of Directors or Certain Officers
8:09am
8-K
4dsw y60jpqhcw
11 May 20
Applied Therapeutics Reports First Quarter 2020 Financial Results
7:07am
8-K
8e6mmk5jwi
21 Apr 20
Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial
7:29am
8-K
oh101edxrtf xoj
1 Apr 20
Departure of Directors or Certain Officers
5:11pm
8-K
3dq819e5q vt7nroxn4
13 Mar 20
Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial Results
7:01am
8-K
u5213
14 Feb 20
Other Events
5:02pm
8-K
8aqbetr tn0g
13 Nov 19
Applied Therapeutics Reports Third Quarter 2019 Financial Results
7:15am
8-K
muym4a18q6bg8rw8yaip
12 Nov 19
Applied Therapeutics, Inc. Announces Pricing of $20 Million Private Placement of Common Stock
9:24am
8-K
9tzmzxkdbk6
4 Sep 19
Departure of Directors or Certain Officers
5:06pm
8-K
uq8sfqpgvtpg4729vxhr
4 Sep 19
Other Events
8:00am
8-K
cddfa
12 Aug 19
Applied Therapeutics Reports Second Quarter 2019 Financial Results
7:16am
8-K
fp2hcbs0bnufo3wj
8 Aug 19
Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study
7:00am
8-K
fzs5p
6 Aug 19
Regulation FD Disclosure
8:10am